InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,616.84
(
-0.32%
)
US TECH 100
18,992.00
(
-1.08%
)
Dow Jones
41,240.52
(
0.16%
)
Brent Oil
80.24
(
-0.04%
)
Bitcoin
63,055.22
(
0.29%
)
Post# of 252977
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 151883

Wednesday, 11/07/2012 1:14:43 PM

Wednesday, November 07, 2012 1:14:43 PM

Post# of 252977
AUXL:

Considering some data indicates parts of Europe has a much higher rate Dupuytrens this isn't good news for sales. Since they got Actelion as a partner in Canada I imagine they are the likely one to pick up Europe. I wonder if Pfizer didn't see the potential or didn't like the data for Peyronie's.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up